BCIP Life Sciences Associates, LP is 10% Owner at Xilio Therapeutics, Inc. (XLO). They have made 3 open-market trades across 3 companies since 2019, most recently 2021-12-10.
CIK 0001702921
2 open-market purchases totalling $10.7M since 2020, against 1 sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.